Vaginal discharge resident survival guide: Difference between revisions
Agnesrinky (talk | contribs) |
Agnesrinky (talk | contribs) |
||
Line 209: | Line 209: | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''Over-the-Counter Intravaginal Agents'''<ref name="urlVulvovaginal Candidiasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/candidiasis.htm |title=Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''Over-the-Counter Intravaginal Agents'''<ref name="urlVulvovaginal Candidiasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/candidiasis.htm |title=Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
* [[Clotrimazole]] 1% cream 5 g intravaginally daily for 7–14 days | *[[Clotrimazole]] 1% cream 5 g intravaginally daily for 7–14 days | ||
OR | OR | ||
* [[Clotrimazole]] 2% cream 5 g intravaginally daily for 3 days | |||
*[[Clotrimazole]] 2% cream 5 g intravaginally daily for 3 days | |||
OR | OR | ||
* [[Miconazole]] 2% cream 5 g intravaginally daily for 7 days | |||
*[[Miconazole]] 2% cream 5 g intravaginally daily for 7 days | |||
OR | OR | ||
* [[Miconazole]] 4% cream 5 g intravaginally daily for 3 days | |||
*[[Miconazole]] 4% cream 5 g intravaginally daily for 3 days | |||
OR | OR | ||
* [[Miconazole]] 100 mg vaginal suppository, one [[suppository]] daily for 7 days | |||
*[[Miconazole]] 100 mg vaginal suppository, one [[suppository]] daily for 7 days | |||
OR | OR | ||
* [[Miconazole]] 200 mg vaginal suppository, one [[suppository]] for 3 days | |||
*[[Miconazole]] 200 mg vaginal suppository, one [[suppository]] for 3 days | |||
OR | OR | ||
* [[Miconazole]] 1,200 mg vaginal [[suppository]], one [[suppository]] for 1 day | |||
*[[Miconazole]] 1,200 mg vaginal [[suppository]], one [[suppository]] for 1 day | |||
OR | OR | ||
* [[Tioconazole]] 6.5% [[ointment]] 5 g intravaginally in a single application | |||
*[[Tioconazole]] 6.5% [[ointment]] 5 g intravaginally in a single application | |||
'''Prescription Intravaginal Agents:''' | '''Prescription Intravaginal Agents:''' | ||
* [[Butoconazole]] 2% cream (single dose bioadhesive product), 5 g intravaginally in a single application | *[[Butoconazole]] 2% cream (single dose bioadhesive product), 5 g intravaginally in a single application | ||
OR | OR | ||
* [[Terconazole]] 0.4% cream 5 g intravaginally daily for 7 days | |||
*[[Terconazole]] 0.4% cream 5 g intravaginally daily for 7 days | |||
OR | OR | ||
* [[Terconazole]] 0.8% cream 5 g intravaginally daily for 3 days | |||
*[[Terconazole]] 0.8% cream 5 g intravaginally daily for 3 days | |||
OR | OR | ||
* [[Terconazole]] 80 mg [[Vagina|vaginal]] [[suppository]], one [[suppository]] daily for 3 days | |||
*[[Terconazole]] 80 mg [[Vagina|vaginal]] [[suppository]], one [[suppository]] daily for 3 days | |||
'''Oral Agent:''' | '''Oral Agent:''' | ||
* [[Fluconazole]] 150 mg orally in a single dose | *[[Fluconazole]] 150 mg orally in a single dose | ||
Line 248: | Line 270: | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
* [[Metronidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | *[[Metronidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
OR | OR | ||
* [[Tinidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*[[Tinidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
<br /> | <br /> | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
* Metronidazole 500 mg orally twice a day for 7 days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | *Metronidazole 500 mg orally twice a day for 7 days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
OR | OR | ||
* [[Clotrimazole]] 2 X 100 mg [[Vagina|vaginal]] tabs QHS for 7days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*[[Clotrimazole]] 2 X 100 mg [[Vagina|vaginal]] tabs QHS for 7days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
* | |||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Bacterial Vaginosis]] | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Bacterial Vaginosis]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
* Metronidazole 500 mg orally twice a day for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | *Metronidazole 500 mg orally twice a day for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
OR | OR | ||
* Metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*Metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | OR | ||
* Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
* Tinidazole 2 g orally once daily for 2 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | *Tinidazole 2 g orally once daily for 2 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
OR | OR | ||
* Tinidazole 1 g orally once daily for 5 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*Tinidazole 1 g orally once daily for 5 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | OR | ||
* Clindamycin 300 mg orally twice daily for 7 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*Clindamycin 300 mg orally twice daily for 7 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | OR | ||
* Clindamycin ovules 100 mg intravaginally once at bedtime for 3 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*Clindamycin ovules 100 mg intravaginally once at bedtime for 3 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Neisseria gonorrheae|Neisseria gonorrhoea]] | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Neisseria gonorrheae|Neisseria gonorrhoea]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
[[Amoxicillin]] orally 3 gm single [[dose]] <br> or <br>[[Ampicillin]] [[Oral|orally]] 3.5 gm single dose <br> or <br>[[Procaine]] PCN G 4.8 million IM single [[dose]] | [[Amoxicillin]] orally 3 gm single [[dose]] <br> or <br>[[Ampicillin]] [[Oral|orally]] 3.5 gm single dose <br> or <br>[[Procaine]] PCN G 4.8 million IM single [[dose]] | ||
Line 299: | Line 339: | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | ||
[[Acyclovir]] | [[Acyclovir]] | ||
Revision as of 09:33, 4 February 2021
Vaginal discharge Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Dos |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Synonyms and keywords: Approach to Vaginal discharge, Leukorrhea
Overview
Vaginal discharge is a common complaint in primary care which can be a subjective complaint or an objective finding. So, it is important to differentiate between normal physiological discharge and pathological discharge. Vaginal discharge is a mixture of liquid, cells, and bacteria that lubricate and protect the vagina. It is produced by the cells of the vagina and cervix. Normal vaginal discharge changes with the menstrual cycle, such as the character of the discharge is clearer with a stretchable consistency around ovulation, then may be thicker and slightly yellow during the luteal phase. Normal healthy discharge should not be associated with symptoms such as itching, redness and swelling, and does not have a strong odour. It is important to take complete history and ask about the associated symptoms like dysuria, dyspareunia, lower abdominal pain, itching, fever. While considering the causes, it is necessary to distinguish between the infectious and non-infectious causes. The infectious causes are infection with Candida albicans, Trichomonas vaginalis, Gardnerella vaginalis, Chlamydia trachomatis, Neisseria gonorrhea, Herpes Simplex Virus. Diagnosis must be confirmed by laboratory tests and cultures. Non-infectious causes include puberty, menstrual cycle, foreign body, cervical cancer, vaginal cancer, diabetes etc. Treatment depends on the cause of the discharge.
Causes
Infectious causes
Non-sexually transmitted infection[1]:
- Bacterial vaginosisis mostly happens during the reproductive age of women characterized by a shift in the vaginal flora from the dominant Lactobacillus to a polymicrobial flora.[2]
Sexually transmitted infection:
- Trichomoniasis,a parasitic infection typically contracted and caused by having unprotected sex[5]
Non-infective causes
Physiological[1]:
Non-physiological:
- Drug side effect as antibiotic or steroid use as, Amoxicillin and Clavulanic Acid , Butoconazole Vaginal Cream , Clotrimazole , Combined oral contraceptive pill, Estradiol Topical , Estradiol Transdermal , Estrogen and Progestin (Oral Contraceptives) ,Estrogen Injection , Estrogen Vaginal , Etonogestrel and Ethinyl Estradiol Vaginal Ring , Glatiramer Injection ,Hormone replacement therapy (trans), Letrozole, Leuprolide , Medroxyprogesterone Injection , Metronidazole Topical ,Miconazole , Nafarelin , Natalizumab injection , Norelgestromin and ethinyl estradiol transdermal system , Ospemifene, Oxcarbazepine , Pramipexole, Progesterone, Tamoxifen , Terconazole Vaginal Cream, Vaginal Suppositories , Toremifene, Zoledronic Acid Injection
- Gynaecological causes:
- Atrophic vaginitis or senile vaginitis, it as a result of estrogen deficiency lead to vaginal dryness, itching, irritation, discharge, and dyspareunia.[6]
- Vulval dermatitis
- Cervical ectopy
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Vaginal discharge.
Abbreviations: BP: Blood pressure, RR=Respiratory rate, HR=Heart Rate, OCP= Oral Contraceptive Pill, NAAT= Nucleic Acid Amplification Test
Patient with history of Vaginal discharge | |||||||||||||||||||||||||||||||||||||||||||||||
Take complete history | |||||||||||||||||||||||||||||||||||||||||||||||
Ask the following questions about menstrual history : ❑ Age of menarche ❑ Last menstrual period ❑ Is the menstrual flow normal? How many pads she has to use in a day? ❑ Is there any foul smell or colour change? ❑ How many days does the menstrual period stay? ❑ Contraceptive history for example oral contraceptives, intrauterine device | |||||||||||||||||||||||||||||||||||||||||||||||
Ask the following questions about general health : ❑ Ask about medical and drug history including recent antibiotic use and type of contraceptive use ❑ Assess for the possibility of a foreign body in situ ❑ Ask if there was any surgery or instrumentation to the genital region recently ❑ Is there any other health conditions like Diabetes Mellitus? ❑ Is there any history of fever, lower abdominal pain? | |||||||||||||||||||||||||||||||||||||||||||||||
Ask the following questions about colour, appearance of the discharge | |||||||||||||||||||||||||||||||||||||||||||||||
Is the discharge white or cream coloured, resembling "cottage cheese"? | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||
Check if they have the following complains : ❑ Pruritus ❑ Vaginal Burning, usually with increased vaginal discharge ❑ Vague but inoffensive odour ❑ Dysuria, dyspareunia in patients with intense scratching and itching that led to skin excoriations ❑ Presence of vulval erythema, fissures | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | |||||||||||||||||||||||||||||||||||||||||||||||
Ask if the following factors are present | |||||||||||||||||||||||||||||||||||||||||||||||
Associated factors: ❑ Diabetes Mellitus ❑Obesity ❑ Pregnancy ❑ Recent use of steroids/ antibiotics/ immunosuppressive agents | |||||||||||||||||||||||||||||||||||||||||||||||
Examination of direct vaginal secretions or scrapping from vaginal wall via direct microscopy | |||||||||||||||||||||||||||||||||||||||||||||||
When a drop of 10% Potassium Hydroxide is added, typical myecelis or pseudo hyphae is seen | |||||||||||||||||||||||||||||||||||||||||||||||
Candidiasis | |||||||||||||||||||||||||||||||||||||||||||||||
Is the discharge greenish? | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||
Check if they have the following complains : ❑ Purulent, frothy discharge ❑ Foul smelling discharge with vulval soreness and irritation, if severe vulval oedema ❑ Punctate hemorrhagic area or strawberry cervix is path gnomic ❑ Lower abdominal pain anddyspareunia may be seen in patients with long standing infection ❑ Male partners are usually asymptomatic except having penile pruritus after coitus | |||||||||||||||||||||||||||||||||||||||||||||||
Wet mount test: a drop of vaginal secretion is mixed with saline and examined under microscope | |||||||||||||||||||||||||||||||||||||||||||||||
Trichomonads are recognised by their twitching motility | |||||||||||||||||||||||||||||||||||||||||||||||
Vaginal pH > 5 helps to distinguish between trichomoniasis and candidiasis which has pH of less than 4.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Trichomoniasis | |||||||||||||||||||||||||||||||||||||||||||||||
Is the discharge thin, homogenous, bubbly? | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | Herpes Simplex | |||||||||||||||||||||||||||||||||||||||||||||
Check if they have the following complains : ❑ Malodorous, fishy discharge ❑ No itching or discomfort ❑No inflammation of vulva | While it does not produce vaginal discharge itself, it causes cervicitis and vaginitis that are associated with severe leukorrhea | ||||||||||||||||||||||||||||||||||||||||||||||
Associated factors: ❑ Vary in intensity during menstrual cycle, worse at mid-cycle and especially after intercourse | |||||||||||||||||||||||||||||||||||||||||||||||
Whiff test: When a drop of 10% potassium hydroxide is added to a drop of vaginal secretion fishy amine odour is released | |||||||||||||||||||||||||||||||||||||||||||||||
Vaginal pH > 5 with presence of clue cells are diagnostic | |||||||||||||||||||||||||||||||||||||||||||||||
Bacterial vaginosis (Gardnerella vaginosis) | |||||||||||||||||||||||||||||||||||||||||||||||
Mucopurulent discharge | |||||||||||||||||||||||||||||||||||||||||||||||
Neisseria gonorrhoea | Chlamydia trachomatis | ||||||||||||||||||||||||||||||||||||||||||||||
Check if they have the following complains : ❑ Mucopurulent cervicitis and urethritis ❑ Dysuria, urethral irritation ❑Infection of peri-urethral glands and Bartholin's duct ❑ As infection progresses, patient may experience abdominal pain. | Check if they have the following complains : ❑ Watery, thinner discharge with dysuria and lower abdominal discomfort ❑ Cervical friability and oedema with ectopy of cervix ❑ Infection of peri-urethral glands and Bartholin's duct | ||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis : ❑ Culture of endo-cervical specimen shows gram negative diplococci, Neisseria gonorrhoea | Diagnosis : ❑First void urine and vaginal swabs are the recommended specimens for NAAT( Nucleic Acid Amplification Test) for diagnosis of Chlamydia trachomatis.[7] | ||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of Vaginal discharge.
Abbreviations: QHS : Every bedtime , BID: 2 times daily, TID: Three times a day, QID: Four times a day, IM :Intramuscular
Organisms | Recommended Drugs | Alternative drugs |
---|---|---|
Candidiasis | Over-the-Counter Intravaginal Agents[8]
OR
OR
OR
OR
OR
OR
OR
Prescription Intravaginal Agents:
OR
OR
OR
Oral Agent:
|
Nystatin 1,00,000 unit tab vaginally QHS for 2 weeks |
Trichomoniasis |
OR
|
OR
|
Bacterial Vaginosis |
OR
OR
|
OR
OR
OR
|
Neisseria gonorrhoea |
Amoxicillin orally 3 gm single dose
|
Erythromycin 500 mg orally QID for 7 days or Tetracycline 500 mg orally QID for 7 days or Doxycycline 100 mg orally BID for 7 days or Spectinomycin 2 gm IM single dose |
Chlamydia trachomatis | Tetracycline 500 mg orally QID for 7 days or Doxycycline 100 mg orally BID for 7 days |
Erythromycin base 500 mg orally QID for 7 days or Erythromycin ethylsuccinate 800 mg orally QID for 7 days or Sulfamethoxazole 1gm orally BID for 10 days
|
Herpes Simplex |
|
Patient should be referred to a gynaecologist if following are present. [11]
- Retained foreign bodies.
- Recent instrumentation or surgery of the genital tract such as hysterosalpingography, dilation and curettage, hysteroscopy, termination of pregnancy/evacuation of retained products of conception, laparoscopy and major gynaecological surgical procedure.
- Suspected tumour of the genital tract.
- Cervical ectopy or polyps.
- Recurrent vulvovaginal candida infections.
- Pregnant woman with abnormal vaginal discharge
- Symptoms of upper genital tract infections as fever, lower abdominal pain
Dos
- The use of topical azole formulations can weaken latex condoms and diaphragms. This risk should be mentioned to the woman prior to starting these medications.[11]
- Referral to a gynaecologist should be considered if there is a history of recent instrumentation or surgery of the genital tract, retained foreign body, cervical ectopy or polyp, or suspicion of tumour on examination; or in women with symptoms of upper genital tract infection or recurrent vulvovaginal candida infections, pregnant women with abnormal vaginal discharge, or women who have failed routine treatment strategies.[11]
- Women should be advised to avoid alcohol consumption during treatment for up to 24 hours after completion of Metronidazole or 72 hours after completion of Tinidazole to reduce the possibility of a disulfiram-like reaction.[11][10]
- Women with Trichomoniasis should be advised to abstain from sexual intercourse until treatment is completed and symptoms have resolved, as it is sexually transmissible.[11][9]
Don'ts
- Patient should be advised to avoid tight-fitting synthetic clothing.[11]
- Patient should be told to avoid local irritants such as perfumed products and soap gels, and vaginal douching.
- There is no clear and consistent evidence across currently published studies regarding the role of probiotics for vaginal health.[11]
References
- ↑ 1.0 1.1 Watson WJ, Demarchi G (August 1987). "Vaginal discharge: an approach to diagnosis and management". Can Fam Physician. 33: 1847–52. PMC 2218224. PMID 21263805.
- ↑ Cettl L, Dvorak J, Felkel H, Feuereisl R (1979). "Results of simulation of non-homogeneous ventilatory mechanics for a patient-computer arrangement". Int J Biomed Comput. 10 (1): 67–74. doi:10.1016/0020-7101(79)90042-4. PMID http://www.ncbi.nlm.nih.gov/pmc/articles/pmc478688 Check
|pmid=
value (help). - ↑ 3.0 3.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1016/j.ogrm.2016.08.002 Check
|pmid=
value (help). - ↑ Wathne B, Holst E, Hovelius B, Mårdh PA (1994). "Vaginal discharge--comparison of clinical, laboratory and microbiological findings". Acta Obstet Gynecol Scand. 73 (10): 802–8. doi:10.3109/00016349409072509. PMID https://pubmed.ncbi.nlm.nih.gov/7817733 Check
|pmid=
value (help). - ↑ Spence D, Melville C (2007). "Vaginal discharge". BMJ. 335 (7630): 1147–51. doi:10.1136/bmj.39378.633287.80. PMC 2099568. PMID https://pubmed.ncbi.nlm.nih.gov/18048541 Check
|pmid=
value (help). - ↑ Hainer BL, Gibson MV (2011). "Vaginitis". Am Fam Physician. 83 (7): 807–15. PMID 21524046.
- ↑ Meyer T (August 2016). "Diagnostic Procedures to Detect Chlamydia trachomatis Infections". Microorganisms. 4 (3). doi:10.3390/microorganisms4030025. PMC 5039585. PMID 27681919.
- ↑ "Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines".
- ↑ 9.0 9.1 9.2 9.3 9.4 "Trichomoniasis - 2015 STD Treatment Guidelines".
- ↑ 10.0 10.1 10.2 10.3 10.4 10.5 10.6 10.7 "Bacterial Vaginosis - 2015 STD Treatment Guidelines".
- ↑ 11.0 11.1 11.2 11.3 11.4 11.5 11.6 Sim, M; Logan, S; Goh, LH (2020). "Vaginal discharge: evaluation and management in primary care". Singapore Medical Journal: 297–301. doi:10.11622/smedj.2020088. ISSN 0037-5675.